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Malignant minor salivary gland tumors: a retrospective study of
27 cases
Abstract
PURPOSE: Malignant tumors of the intra-oral minor salivary glands are uncommon. The aim of this
study was to give information concerning the clinical features of these tumors, the distribution of
location, treatment opportunities, and outcome. METHODS: Twenty-seven patients with malignant
salivary gland tumors that were treated between January 1999 and December 2008 were evaluated
retrospectively. RESULTS: Of the 27 minor salivary gland carcinomas, 48.1% were adenoid cystic
carcinomas (ACC), 29.7% mucoepidermoid carcinomas (MEC), 22.2% adenocarcinomas (ADCA). The
most common first symptom was a painless swelling in 60% of the cases, with the second most common
symptom being ulcers (28%). Four recurrences and two metastases were found. No recurrence was
observed in ADCA. All four patients experiencing a recurrence developed it in the first 3 years after
treatment. CONCLUSION: Wide excision with a clinical margin of 1 cm and in large tumors, positive
surgical margins or perineural infiltration and postoperative radiotherapy (RT) can be recommended; but
in order to give exact information concerning the possible benefit from postoperative RT, it needs large
prospective multicenter studies. Long-term follow-up controls and in particularly longer than 5 years in
ACC including yearly chest X-rays should be offered to these patients because of late metastasis and
recurrences.
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ABSTRACT 
Purpose Malignant tumors of the intra-oral minor salivary glands are uncommon. 
The aim of this study was to give information concerning the clinical features of 
these tumors, the distribution of location, treatment opportunities, and outcome. 
Methods: Twenty-seven patients with malignant salivary gland tumors that were 
treated between January 1999 and December 2008 were evaluated 
retrospectively.  
Results: Of the 27 minor salivary gland carcinomas, 48.1% were adenoid cystic 
carcinomas (ACC), 29.7% mucoepidermoid carcinomas (MEC), 22.2% 
adenocarcinomas (ADCA). The most common first symptom was a painless 
swelling in 60% of the cases, with the second most common symptom being ulcers 
(28%). Four recurrences and two metastases were found. No recurrence was 
observed in ADCA. All four patients experiencing a recurrence developed it in the 
first 3 years after treatment. 
Conclusion: Wide excision with a clinical margin of 1 cm and in large tumors, 
positive surgical margins or perineural infiltration and postoperative radiotherapy 
(RT) can be recommended; but in order to give exact information concerning the 
possible benefit from postoperative RT, it needs large prospective multicenter 
studies. Long-term follow-up controls and in particularly longer than 5 years in ACC 
including yearly chest X-rays should be offered to these patients because of late 
metastasis and recurrences.  
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INTRODUCTION 
 
Between 450 and 750 minor glands can be found scattered throughout the head 
and neck and are present in many sites, such as the lips, cheek, gingival, palate, 
tongue, oropharynx, parapharyngeal space, and paranasal sinuses [1]. Malignant 
tumors of the intra-oral minor salivary glands constitute 2-3% of all malignant 
neoplasms of the upper aerodigestive tract and less than 25% of all salivary gland 
tumors [2]. Tumors arising at major salivary glands due to their well-defined 
anatomic borders and their higher incidence cannot be directly compared to minor 
salivary gland tumors. Most tumors arising at minor salivary glands are malignant. 
The pathogenesis is still not completely solved, but factors like smoking, poor 
mouth hygiene or alcohol abuse seems to play not the same rule like in oral 
squamous cell carcinoma. The most common sites are the hard palate, nasal 
cavity, and paranasal sinuses [3]. Squamous cell carcinomas of the oral cavity are 
well studied, but malignant tumors of the minor salivary glands are rare. However, 
controversy still surrounds several issues including length of follow-up time and 
indications for radiotherapy (RT). Most of the studies that are available are 
retrospective studies. 
The purpose of this study was to determine the histological types, sites and 
prognostic factors of patients with malignant minor salivary gland carcinomas and 
to compare the results with data from different reports.  
 
 
PATIENTS  
 
The records of all patients with malignant minor salivary gland tumors from 
January 1999 and December 2008, treated in the Department of 
Craniomaxillofacial and Oral Surgery, University Hospital Zurich were 
systematically reviewed for tumor site, histological type, involvement of lymph 
nodes, metastases, treatment and recurrence. Exclusion criteria were recurrent 
disease plus lack of information, therefore two patients were excluded. In all 
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patients, an incisional biopsy and computed tomography (CT), positron-emissions 
tomography (PET) or magnetic resonance imaging (MRI) was performed before 
the definitive treatment.  
 
 
 
 
RESULTS 
 
 
Age, sex, primary sites, and kinds of carcinoma 
 
Together, 27 patients with intra-oral minor salivary gland tumors were treated and 
evaluated retrospectively. Out of these 27 patients, 48.1% had an adenoid cystic 
carcinoma (ACC), 29.7% mucoepidermoid carcinoma (MEC), and 22.2% an 
adenocarcinoma (ADCA). The female to male ratio was 14:13, and the average 
age for MEC was 47.9 years (28-83 years); for ADCA, 47.3 years (35 - 62 years); 
and for ACC, 64.4 years (36 – 87 years). The most common age period for 
developing a malignant tumor of the intra-oral minor salivary gland was between 
55 and 70 years (Fig. 1). 
The distribution of location is presented in Table 1: in the region of the alveolar 
ridge, the most common minor salivary cancer is ACC; and in the hard palate, it is 
the MEC. Forty-four percent of these tumors are located in the hard palate. 
Regarding the tumors located in the lower jaw, one ACC was located on the 
ascending ramus and one on the alveolar crest in an edentulous region. One MEC 
was located on the alveolar crest in an edentulous region. Figure 2 does give an 
overview about the primary location of all included cases.  
 
 
Sex     ACC  ADCA  MEC 
   Male   6 3 4 
   Female  7 2 4 
Minor site          
 
upper jaw/alvoler 
ridge  5 2 1 
   hard palate  5 2 5 
   soft palate  2 2 1 
   lower jaw  2 0 1 
           
T status  T1  3 2 4 
   T2  5 3 3 
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   T3  2 0 0 
   T4  3 1 1 
           
N status  N1  1 0 0 
   N2a  2 0 0 
   N2b  0 0 0 
   N2c  0 0 0 
   N3  0 0 0 
           
M status  M0  0 0 0 
   M1  1 0 0 
 
 
 
Initial symptoms and therapy 
 
Most patients were referred from private dentists. The most common first 
symptom, found in 60% of patients, was a painless swelling, followed by an ulcer 
(28%).  
 
The tumors in the present study were resected clinically with 1-cm margins. Out of 
27 patients, 5 patients (four with ACC and one with MEC) had a supraomohyoidal 
neck dissection because of clinically positive lymph nodes. Recurrence, positive 
lymph nodes, large tumors, or positive surgical margins were an indication for 
radio- and/or chemotherapy (Table 2). 
 
Treatment results and follow-up strategy 
 
In four out of 27 patients, a recurrence (three in ACC and one in MEC) was 
observed. No recurrence was observed in ADCA (Table 2). 
 
All four patients experiencing a recurrence developed it in the first 3 years after 
treatment. Two patients were treated first in a different hospital, so that the original 
pathohistology was not available. Five patients (all with ACC) had perineural 
infiltration in their first resection, but in only one, recurrence and metastases 
developed until now (Table 3). Neck dissections were only performed in cases of 
clinically positive lymph nodes. The median follow-up time for ACC was 60 months, 
for ADCA 54 months and for MEC 47.9 months (Table 2). The patients were seen 
in the first year on a monthly basis, in the second year every 2 months, in the third 
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year every 3 months, in the forth year every 6 months followed by a yearly control 
(Table 4).  
 
 ACC MEC ADCA 
resection and 
neck dissection 
positive lymph 
nodes 
positive lymph 
nodes 
positive lymph 
nodes 
surgery + RT lymph node 
metastases, R1 
resection, 
recurrent cancer, 
high-grade 
malignancy, 
perineural 
invasion,  
lymph node 
metastases, R1 
resection, 
recurrent cancer, 
high-grade 
malignancy, 
perineural 
invasion, 
lymph node 
metastases, R1 
resection, 
recurrent cancer, 
high-grade 
malignancy, 
perineural 
invasion, 
RT alone unresectable 
tumors 
unresectable 
tumors 
unresectable 
tumors 
follow-up 
(clinical control, 
CT or MRI, yearly 
chest x-rays) 
min.20 years min. 5 years min. 5 years 
 
 
 
 
DISCUSSION 
 
In several studies adenoid cystic carcinoma has been shown as being most 
common [4-6], with several other studies showing, on the other hand, that 
mucoepidermoid carcinoma is the most common (Table 5) [2,7-10]. Some authors 
describe the tumor distribution pattern as varying by country. 
Most reports describe a female predominance in minor salivary gland tumors [4,5] 
similar to the proportion in the present study, which shows female to male as 7:6. 
The main age group was found between 60-79 years: that is also supported in 
other studies [11,12]. Also, the present study shows the palate as the predominant 
 6
location (62.9% in the hard and soft palate), a finding comparable to those of other 
current studies [4,5,10]. Concerning recurrence, only a very few studies are 
available because of late metastasis, older age of patients, and lower incidence of 
these tumors.  
A lower rate of cervical lymph node metastases in comparison to oral squamous 
cell carcinomas has been reported by several authors [1, 13] and this was also 
supported by the present study; in only three out of 27 patients were positive lymph 
nodes found. Therefore, there is probably little benefit from elective neck 
dissection. In this study, neck dissection was performed in patients with clinical or 
radiological suspect on lymph node metastasis or in patients with T4 tumor stage.  
Regarding the initial therapy, there was no difference between the patients 
developing recurrence (Table 3) on one hand and the patients not experiencing 
recurrence on the other hand. 
Further therapy strategies recommend on a type-2 level of evidence [14] in cases 
of unresectable/inoperable locoregional disease neutron, heavy ions or proton 
radiotherapy. But there are still controversies concerning radiotherapy, on the one 
hand surgical resection and postoperative RT is recommended [15]. But on the 
other hand, Spiro et al. could not show a survival benefit for patients receiving 
postoperative RT, after matching for stage, site, and histology [12]. 
Concerning neutron beam, one problem seems to be the limited number of 
institutions providing this treatment besides the reported complication rate like 
osteoradionecrosis, optic neuritis/retinitis, and oral/pharyngeal-cutaneous fistulas 
[14, 16]. 
Due to overlapping clinicopathological features of ACC and polymorphous low-
grade adenocarcinoma (PLGA), the differentiation can be difficult. Up until now, 
only vimentin presents a clear difference, which is negative in ACC and positive in 
PLGA. CEA, EMA and S100 protein can be positive in both tumors [17]. 
Concerning salivary gland tumors, Ki-67 has been discussed as a prognostic factor 
because of being significantly higher in cases of treatment failure and large tumors 
[18], but in clinical routine, the application of Ki-67 is still missing. 
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Adenoid cystic carcinoma 
 
The peak incidence of these tumors was between 60 and 79 years, although the 
literature describes a wide age distribution [18]. Also, the predominance of 
females, as in our study, is confirmed (7:4). Nearly half of all intraoral ACC occur in 
the palate [17]. 
The growth pattern of ACC is described as slow but aggressive, with a 
predominantly perineural spread and less lymphatic spread, but also with more 
frequent distant metastasis (particularly in the lungs) after long-term survival and 
even in the absence of local or regional recurrence [19]. Therefore, it is difficult to 
distinguish between recurrence and a second tumor in adenoid cystic carcinomas. 
Distant metastases, when affecting the lungs, are usually slow growing, sometimes 
apparently isolated, and frequently surgically resectable [20]. The longest time 
elapsing before a distant metastasis in the present study was 68 months. 
Compared to other head and neck malignancies, ACC are more difficult to clear 
surgically, often resulting in positive margins [17]. In the present study, only in one 
case was a second resection performed immediately after histopathological 
diagnosis of involved margin (not detected in frozen section), this patient showed 
no recurrence or metastases.  
Predictors for distant metastasis seem to be large tumor size and lymph node 
involvement [21]. Therefore, initial aggressive surgery, combined with radiation for 
high-stage tumors or involved surgical margins, is suggested [18, 21].  
These principles were also used in the present study.  
 
Mucoepidermoid carcinoma 
 
MEC was indicated in 32% of the cases as the second most common type of 
tumor. The female to male ratio was 1:1. 
In contrast to ACC, MEC show their malignant behaviour within the first 5 years 
after surgery [18, 22]. In only one case out of eight was a recurrence seen after 14 
months and resected again. An increase of Ki-67 has been discussed in order to 
differentiate between malignant and benign gland tissue [18, 23] but has not been 
established in clinical routine to date. Although radio-resistance is discussed, 
radiation is recommended in patients with positive surgical margins and high-grade 
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tumors [15, 24]. Tran et al. reported an improvement of local control by RT in 
patients with positive surgical margins from 50% to 71% [25]. Recurrence of MEC 
appears mostly in the first 5 years after surgery [18]. 
 
Adenocarcinoma 
 
A predominance in female patients was also described by Pogodzinski et al. [26]. 
No recurrence was found in the patients in the present study but delayed local 
recurrences and regional nodal metastases have been mentioned in the literature 
[26-28]. In contrast to adenoid cystic carcinoma, adenocarcinoma has an excellent 
cure rate after complete excision infrequent recurrences and rare regional 
metastasis [29]. In the present study, no recurrence or metastasis was observed in 
this patient group.  
 
Limitations  
 
The main weakness of this study was the small number of patients. Within the 
limitations of this investigation, the results show the need of long follow-up times in 
patients with ACC. Also, there were considerable differences in the surgical and 
postoperative follow-up protocols, as well as in the length of follow-up time. Most of 
those protocols suffer from a lack of long-term results: most studies cover less than 
5 years of postoperative controls; and, due to the higher age of this patient group, 
long-term controls are not always possible. 
 
 
Author Year n ACC ADCA MEC others 
Vander 
Poorten VL 
2000 55 2210 5 9 16 
Jansisyanont 
P 
2002 61 7 9 33 9 
Strick MJ 2004      
Toida M 2005 27 10 0 8 6 
Yih WY 2005 94 22 18 45 8 
Pires FR 2006 241 35 28 125 32 
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Copelli C 2007 43 26 1 12 2 
Buchner A 2007 156 24 27 83 16 
Mücke T 2009 95 33 14 20 28 
 
 
Therapy 
 
Postoperative RT should be recommended for patients with high-grade 
malignancies, lymph node metastases, perineural invasion and recurrent cancer. It 
is mentioned that RT alone can cure patients with minor salivary gland malignancy, 
but the overall survival rates are lower compared to RT in combination with surgery 
[3].  
 
Prognosis 
 
Concerning prognosis, one must differ between oral and paranasal sinus 
malignancies, the latter seems to be associated with advanced-stage lesions, bone 
invasion, nerve involvement, adenoid cystic carcinoma and positive margins [30]. 
Probably, in these cases, one should consider proton beam RT in order to reduce 
complications associated with central nervous system or visual apparatus. 
Vander et al. and Spiro et al. recommend that the oral squamous cell carcinoma 
TNM classification as one of the major prognostic factor for all oncologic outcomes 
after diagnosis of minor salivary gland carcinoma [11, 12]. Our small study 
indicated that perineural infiltration is not directly associated with distant 
metastases, but for exact evaluation it needs larger and longer studies.  
Seventy percent of local recurrences are observed within 3 years. But there is a 
clear exception in cases of high-grade and adenoid cystic histology [31]. Therefore, 
along with Guzzo et al., we recommend a follow-up period of 20 years in particular 
in adenoid cystic carcinomas or high-grade tumors including yearly chest x-rays. 
 
 
 
CONCLUSION  
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Wide excision with a clinical margin of 1 cm and in large tumors, positive surgical 
margins or perineural infiltration additional postoperative radiotherapy can be 
recommended. But in order to give exact information concerning the possible 
benefit from postoperative radiotherapy, it needs large prospective multicenter 
studies. Long-term follow-up controls and in particularly longer than 5 years in 
adenoid cystic carcinomas including yearly chest X-rays should be offered to these 
patients because of late metastasis and recurrences. 
 
 
 
REFERENCES 
 
1. Rivera-Bastidas H, Ocanto RA, Acevedo AM. Intraoral minor salivary gland tumors: 
a retrospective study of 62 cases in a Venezuelan population. J Oral Pathol Med. 
1996 Jan;25(1):1-4. 
2. Wang D, Li Y, He H, Liu L, Wu L, He Z. Intraoral minor salivary gland tumors in a 
Chinese population: a retrospective study on 737 cases. Oral Surg Oral Med Oral 
Pathol Oral Radiol Endod. 2007 Jul;104(1):94-100. Epub 2006 Oct 24. 
3. Toida M, Shimokawa K, Makita H, Kato K, Kobayashi A, Kusunoki Y, Hatakeyama 
D, Fujitsuka H, Yamashita T, Shibata T. Intraoral minor salivary gland tumors: a 
clinicopathological study of 82 cases. Int J Oral Maxillofac Surg. 2005 
Jul;34(5):528-32. 
4. Takahashi H, Fujita S, Tsuda N, Tezuka F, Okabe H. Intraoral minor salivary gland 
tumors: a demographic and histologic study of 200 cases. Tohoku J Exp Med. 
1990 Jun;161(2):111-28 
5. Buchner A, Merrell PW, Carpenter WM. Relative frequency of intra-oral minor 
salivary gland tumors: a study of 380 cases from northern California and 
comparison to reports from other parts of the world. J Oral Pathol Med. 2007 
Apr;36(4):207-14 
6. Jaber MA. Intraoral minor salivary gland tumors: a review of 75 cases in a Libyan 
population. Int J Oral Maxillofac Surg. 2006 Feb;35(2):150-4. 
7. Yih WY, Kratochvil FJ, Stewart JC. Intraoral minor salivary gland neoplasms: 
review of 213 cases. J Oral Maxillofac Surg. 2005 Jun;63(6):805-10. 
8. Lopes MA, Kowalski LP, da Cunha Santos G, Paes de Almeida O. A 
clinicopathologic study of 196 intraoral minor salivary gland tumours. J Oral Pathol 
Med. 1999 Jul;28(6):264-7. 
9. Le QT, Birdwell S, Terris DJ, Gabalski EC, Varghese A, Fee W Jr, Goffinet DR. 
Postoperative irradiation of minor salivary gland malignancies of the head and 
neck. Radiother Oncol. 1999 Aug;52(2):165-71. 
 11
10. Triantafillidou K, Dimitrakopoulos J, Iordanidis F, Koufogiannis D. Management of 
adenoid cystic carcinoma of minor salivary glands. J Oral Maxillofac Surg. 2006 
Jul;64(7):1114-20. 
11. van der Wal JE, Becking AG, Snow GB, van der Waal I. Distant metastases of 
adenoid cystic carcinoma of the salivary glands and the value of diagnostic 
examinations during follow-up. Head Neck. 2002 Aug;24(8):779-83 
12. Spiro RH. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J 
Surg. 1997 Nov;174(5):495-8. 
13. Brandwein MS, Ivanov K, Wallace DI, Hille JJ, Wang B, Fahmy A, Bodian C, Urken 
ML, Gnepp DR, Huvos A, Lumerman H, Mills SE. Mucoepidermoid carcinoma: a 
clinicopathologic study of 80 patients with special reference to histological grading. 
Am J Surg Pathol. 2001 Jul;25(7):835-45. 
14. Hicks J, Flaitz C. Mucoepidermoid carcinoma of salivary glands in children and 
adolescents: assessment of proliferation markers. Oral Oncol. 2000 Sep;36(5):454-
60. 
15. Hosokawa Y, Shirato H, Kagei K, Hashimoto S, Nishioka T, Tei K, Ono M, Ohmori 
K, Kaneko M, Miyasaka K, Nakamura M. Role of radiotherapy for mucoepidermoid 
carcinoma of salivary gland. Oral Oncol. 1999 Jan;35(1):105-11. 
16. Pogodzinski MS, Sabri AN, Lewis JE, Olsen KD. Retrospective study and review of 
polymorphous low-grade adenocarcinoma. Laryngoscope. 2006 
Dec;116(12):2145-9. 
17. Evans HL, Luna MA. Polymorphous low-grade adenocarcinoma: a study of 40 
cases with long-term follow up and an evaluation of the importance of papillary 
areas. Am J Surg Pathol. 2000 Oct;24(10):1319-28. 
18. Castle JT, Thompson LD, Frommelt RA, Wenig BM, Kessler HP. Polymorphous 
low grade adenocarcinoma: a clinicopathologic study of 164 cases. Cancer. 1999 
Jul 15;86(2):207-19. 
 
 
Legend 
 
Table 1: Distribution of carcinomas 
Table 2: Distribution of age 
Table 3: Distribution of localization 
Table 4: Number of patients that underwent different therapies 
Table 5: Number of patients with recurrence 
 
Table 6: Months till recurrence in five patients (blue) and metastasis in one patient (red) occurred 
Table 7: Comparison of the frequency (%) of malignant intra-oral minor salivary gland tumors among various countries 
 
 
